Sinus & Nasal Congestion: A Nutrition and Natural-Health Reference
1. Definition and Clinical Presentation
Nasal congestion — also called nasal obstruction or stuffiness — refers to the subjective and objective narrowing of the nasal airway resulting in impaired airflow through one or both nasal passages. It is not a discrete disease but rather a symptom complex that arises from a broad spectrum of upper-airway conditions. Rhinosinusitis, a closely related term, denotes concurrent inflammation of the nasal passages and one or more of the paranasal sinuses.
Nasal congestion or obstruction is one of the most frequent symptoms encountered in primary care and specialist clinics, and it is often the predominant symptom in upper respiratory tract disorders such as allergic rhinitis, rhinosinusitis, nonallergic rhinitis, and nasal polyposis. Additionally, nasal congestion is a common symptom in otitis media and asthma, and it can contribute to the onset or worsening of sleep disturbances, including obstructive sleep apnea.
As a clinical term, rhinitis refers to a heterogeneous group of nasal disorders characterized by one or more of the following symptoms: sneezing, nasal itching, rhinorrhea, and nasal congestion. Rhinitis can be caused by allergic, nonallergic, infectious, hormonal, occupational, and other factors. Allergic rhinitis is the most common type of chronic rhinitis, but 30% to 50% of patients with rhinitis have nonallergic triggers.
Severe congestion can result in facial pressure and pain, as well as dark circles under the eyes. Post-nasal drip, reduced olfaction, sleep disruption, and muffled hearing are also characteristic accompaniments. The pattern of symptoms — whether seasonal, perennial, or episodic — carries diagnostic significance. Preliminary data suggest that 44% to 87% of patients with rhinitis might have mixed rhinitis, a combination of allergic and nonallergic rhinitis, and worldwide the prevalence of allergic rhinitis continues to increase.
2. Anatomy and Body Systems Involved
2.1 The Nasal and Paranasal Architecture
The nasal cavity and the paranasal sinuses are covered by a pseudostratified, columnar, ciliated epithelium with a thin mucous layer on top of it. In the sinuses the beat of the cilia is directed toward their natural ostia. These elements combine to condition inhaled air by warming, humidifying, and filtering it.
The ostia of most of the paranasal sinuses lead into the region of the middle meatus and the anterior ethmoid, the osteomeatal complex. Obstruction in this area reduces clearance and plays a major role in the pathophysiology of sinusitis.
The four paired paranasal sinuses — maxillary, frontal, ethmoid, and sphenoid — are air-filled cavities that drain into the nasal cavity. Their normal function depends on patent ostia and intact mucociliary transport. An important mechanism for understanding sinusitis is mucociliary clearance.
2.2 The Nasal Cycle
The nasal cycle leads to a spontaneous alternation of congestion and decongestion between the left and right sides of the cavity. This physiological rhythm, driven by the autonomic nervous system, means that a degree of unilateral nasal resistance is entirely normal. Pathological congestion occurs when this balance is disrupted or when bilateral obstruction arises.
2.3 Vascular and Inflammatory Mechanisms
Mucosal inflammation is the central pathophysiological mechanism that underlies many of the specific and interrelated factors that contribute to congestion, including increased venous engorgement, increased nasal secretions and tissue swelling/edema.
Inflammation associated with allergic rhinitis and rhinosinusitis can reduce the physical size of the nasal passages by inducing vasodilatation, increasing blood flow and increasing vascular permeability. The result is engorgement of nasal venous sinusoids, swelling of the anterior and inferior turbinates and obstruction of nasal airflow, ultimately contributing to nasal congestion.
A wide range of biologically active agents — including histamine, tumor necrosis factor-alpha, interleukins, and cell adhesion molecules — and cell types contribute to inflammation, which can manifest as venous engorgement, increased nasal secretions and tissue swelling/edema, ultimately leading to impaired airflow and the sensation of nasal congestion.
2.4 Neural Pathways
Mediators released by antigen-antibody reactions and by inflammatory processes disrupt nasal function in three main ways. First, mediators such as histamine, bradykinin, and leukotrienes act directly on blood vessels and submucosal glands, causing mucosal thickening and secretion. Second, the same mediators excite terminals of sensory nervous receptors in the nose, setting up axon reflexes with release of neuropeptides from other branches of the nervous receptors.
Action potentials traveling through parasympathetic efferent nerves can lead to glandular activation and rhinorrhea, as well as to some vasodilatation. Suppression of sympathetic neural output, on the other hand, results in vasodilatation and nasal congestion.
2.5 Immune System Involvement in Allergic Rhinitis
In allergic rhinitis, IgE molecules located on a mast cell are bridged by an allergen, triggering the mast cell to release stored and newly generated vasoactive amines such as histamine and proteases. They also generate and secrete products of arachidonic acid such as prostaglandins and leukotrienes, and cytokines such as tumor necrosis factor (TNF). These mediators cause an inflammatory response, vascular dilation, increased vascular permeability, and the recruitment of eosinophils, neutrophils, and Th2 cells. This inflammatory cascade triggers the symptoms of allergic rhinitis, which include sneezing, nasal itching, rhinorrhea, and nasal congestion.
3. Contributing and Associated Factors
3.1 Allergic Triggers
Common allergic triggers include house dust mites, pollens from trees, grasses, shrubs and weeds, animal dander, or fungi, which occur naturally in the environment. Allergic rhinitis can also be caused by triggers to which a person is exposed in the course of their work (occupational exposure), and these may include vegetable proteins, enzymes, and chemicals.
3.2 Infectious Causes
Infectious rhinitis (colds or flu) is typically caused by viruses, with a duration often of 3 to 7 days and sometimes longer. Colds usually begin with a sensation of congestion, rapidly followed by runny nose and sneezing. Sinusitis is produced by a number of pathologic processes, including inflammation of the sinus cavities, poor mucus transport, obstruction of passages from inflammatory debris, and growth of biofilms within the sinuses and their drainage systems.
3.3 Structural and Mechanical Factors
Young children may place intranasal foreign bodies in their noses, leading to foul-smelling, purulent discharge and unilateral nasal obstruction that predisposes to sinusitis. Adenoidal hypertrophy in young children causes bilateral nasal obstruction and is often associated with nocturnal mouth-breathing and snoring. Deviated nasal septum is another structural contributor in which the partition between the two nasal cavities is displaced, narrowing one or both passages.
3.4 Systemic and Hormonal Associations
Wegener's granulomatosis may present with nasal and sinus complaints including purulent rhinorrhea and occasionally septal erosions and perforations. Sjögren's syndrome may cause nasal dryness, congestion, and crusting. Sarcoidosis may present with nasal congestion. Rhinitis of pregnancy is a recognized hormonal subtype driven by elevated estrogen levels affecting the nasal vasculature.
3.5 Non-Allergic (Neurogenic) Rhinitis
Non-allergic rhinitis is characterized by rhinitis symptoms without systemic sensitization or infectious etiology. Based on endotypes, it can be categorized into an inflammatory endotype with usually eosinophilic inflammation and a neurogenic endotype encompassing idiopathic rhinitis, gustatory rhinitis, and rhinitis of the elderly. Rhinitis affects 10–40% of the population in industrialized countries and constitutes a risk factor for asthma, being associated with chronic conditions such as rhinosinusitis.
4. Nutrients, Herbs, and Natural Ingredients
The following subsections document each ingredient, clearly distinguishing traditional use from scientific evidence. Evidence strength is characterized explicitly.
4.1 Zinc
Traditional Use
Zinc-containing preparations have historically been used as astringents and antiseptics in folk medicine across Europe and the Americas. Zinc sulfate and zinc acetate nasal preparations appear in older pharmacopeial literature as local antiseptic and styptic agents for nasal mucosa.
Scientific Evidence
Zinc supplements are commonly recommended and taken for the purpose of preventing colds or shortening their duration. Zinc taken orally, often in the form of lozenges, within 24 hours of symptom onset might reduce the duration of a cold.
A 2020 systematic review of randomized controlled trials found that cold duration and symptom severity was significantly reduced when patients with common cold were provided with a combination of 1,000 mg vitamin C and 10 mg zinc together for 5 days. This was a combination study, limiting attribution to zinc alone.
The evidence base for zinc in upper respiratory tract infections has been challenged by methodological heterogeneity. Some pooled analyses have included trials with a 4,300-fold difference in dosage, making pooling of those trials of questionable value. Overall, evidence for oral zinc lozenges reducing cold duration is promising but inconsistent, and evidence for intranasal zinc has raised safety concerns, including reports of anosmia with some formulations.
4.2 Vitamin C
Traditional Use
The use of vitamin C-rich foods — citrus fruits, rose hips, and acerola — to ward off or shorten respiratory illnesses is deeply embedded in European and South American folk traditions, predating the isolation of ascorbic acid in 1932.
Scientific Evidence
Vitamin C is frequently used for the treatment and prophylaxis of the common cold; however, it is not effective at preventing the common cold in the general adult population, although it is effective at preventing colds when consumed regularly by athletes training in subarctic conditions.
A meta-analysis of ten randomized controlled trials found that the total efficacy, time for symptom amelioration, and time for healing were better with vitamin C supplementation than with antiviral therapy alone, suggesting vitamin C could be used as a supplementary therapy along with antiviral regimens to relieve patients from the symptoms of common cold. The studies in that meta-analysis were conducted in China and used combined antiviral plus vitamin C designs, limiting generalizability.
Overall, Cochrane reviews have consistently found that regular vitamin C supplementation does not reduce cold incidence in the general population but may modestly shorten cold duration and reduce symptom severity — an effect that includes nasal congestion symptoms. The evidence is rated as moderate quality.
4.3 Vitamin D
Traditional Use
Vitamin D was not classically employed as a specific remedy for nasal symptoms in traditional medicine. Its broad role in immune modulation has prompted modern research into its relevance to allergic rhinitis and upper respiratory infections.
Scientific Evidence
Allergic rhinitis is a common condition characterized by symptoms such as sneezing, itching, congestion, and a runny nose. It affects individuals of all ages and is often associated with other allergic diseases such as asthma, with prevalence affecting up to 40% of the population in developed countries.
A 2025 systematic review and meta-analysis incorporating 16 studies (11 RCTs and 5 cohort studies) found that vitamin D significantly reduced total nasal symptom scores (TNSS) (SMD –2.24; 95% CI: –3.05 to –1.43; P < 0.00001), IgE levels, and eosinophil levels in allergic rhinitis patients, with adjuvant vitamin D therapy significantly alleviating nasal symptoms. The very high heterogeneity (I² = 96%) limits firm conclusions, and the authors note that effects differed by patient sex and concomitant medications. The evidence is preliminary-to-moderate in strength; no specific dosage for this indication has been established by regulatory bodies.
4.4 Quercetin
Traditional Use
Quercetin is a polyphenolic flavonoid found abundantly in onions, apples, capers, and buckwheat. Foods rich in quercetin have featured prominently in traditional diets across Europe and Asia without being singled out for nasal conditions specifically, although onion-based folk preparations for coughs and respiratory complaints are documented in European herbal traditions.
Scientific Evidence
Quercetin inhibits mast cell degranulation, reduces the production of histamine and pro-inflammatory cytokines, and restores homeostasis of the immune system by modulating the Th1/Th2 and Treg/Th17 balances. Additionally, its antioxidant properties help to dampen oxidative stress, a critical factor in the pathophysiology of allergic diseases.
In vitro studies have consistently demonstrated quercetin's ability to suppress allergic reactions. In vivo studies, particularly in murine models of allergic rhinitis, have confirmed its efficacy in relieving symptoms such as nasal itching, sneezing, rhinorrhea, and congestion, and in dampening type 2 mucosal inflammation.
However, human studies are still scarce, as only two clinical trials have investigated quercetin as a monotherapy; both reported promising results including symptom reduction and improved quality of life, though larger, randomized trials are needed to validate these findings.
A small clinical study evaluated quercetin phospholipids combined with zinc in subjects with chronic allergic and non-allergic rhinitis. A total of 36 subjects with mild chronic allergic rhinitis, vasomotor non-allergic rhinitis, or chronic drug-induced rhinitis received two tablets daily for 60 days; the results showed that the combination effectively alleviated symptoms of nasal obstruction, rhinorrhea, and sneezing, proposing quercetin's use as a support aid in nasal-sinus disorders, especially of allergic origin. This study was small and uncontrolled, limiting its evidentiary weight. Some laboratory and small human studies suggest quercetin may improve symptoms of allergic rhinitis; however, large, high-quality clinical trials are still limited.
4.5 Bromelain
Traditional Use
Pineapple (Ananas comosus) stem and fruit preparations have a history of use in folk medicine in Central and South America as anti-inflammatory and digestive agents. Proteolytic enzymes from pineapple were studied commercially in Europe — particularly in Germany — as adjuncts for sinusitis from the mid-20th century onward.
Scientific Evidence
The mechanism of action of bromelain appears to extend beyond its proteolytic activity as a digestive enzyme, encompassing mucolytic, anti-inflammatory, anticoagulant, and antiedematous effects.
In the respiratory setting, bromelain has been shown to have good serum and rhinosinusal tissue distribution when administered as a tablet, with symptom relief. It represents an adjunctive treatment for rhinosinusitis with more suggestive evidence of efficacy in acute rather than chronic forms, also in the pediatric population.
A pharmacoepidemiological cohort study examined bromelain in children under 11 with acute sinusitis. The therapeutic efficiency and safety of bromelain was evaluated in 116 patients from 19 centres in Germany. Cohorts were treated with bromelain alone (N=62), in combination with standard therapies (N=34), or with standard therapies alone (N=20). The shortest mean period of symptoms was observed in patients treated with bromelain alone (6.66 days), followed by the standard therapy group (7.95 days). Patients of the bromelain monotherapy group showed a statistically significant faster recovery from symptoms (p = 0.005) compared to the other treatment groups. This was a cohort study, not a randomized controlled trial, which limits the strength of inference.
A pilot study in 12 adults with chronic rhinosinusitis found that bromelain tablets (500 FIP) for three months improved total symptom scores, rhinoscopy scores, and quality-of-life scores, with the effect being more pronounced in chronic rhinosinusitis without nasal polyps than in those with polyps. This was an open-label, uncontrolled pilot study; evidence strength is weak.
4.6 N-Acetylcysteine (NAC)
Traditional Use
NAC is a synthetic derivative of the amino acid cysteine; it has no classical traditional herbal use. It was introduced clinically in the 1960s as a mucolytic for respiratory conditions. Its application to sinusitis represents an extension of its established use in bronchitis and related conditions.
Scientific Evidence
In an early study of 32 sinusitis patients treated with a NAC solution administered by sinus irrigations, the authors concluded that NAC is an effective mucolytic agent. A 1992 review stated that, based on the apparent efficacy and relative safety of oral NAC in chronic bronchitis, controlled trials investigating its use in the treatment of chronic sinusitis should be encouraged.
However, a more recently published phase 3 study in recurrent acute sinusitis did not meet expectations for recommending mucolytics in current treatment guidelines for rhinosinusitis. This study employed only a single-blind design and NAC was given in addition to a nasal corticosteroid. As of the clinical trial protocol filed, the proposed randomized controlled trial represented the first investigation to assess the efficacy and safety of NAC in rhinosinusitis according to current regulatory requirements. Overall, evidence for NAC specifically in sinusitis remains preliminary; the mechanistic rationale — breaking disulfide bonds in mucin to reduce mucus viscosity — is well established, but confirmatory rigorous human trials in rhinosinusitis are lacking.
4.7 Echinacea
Traditional Use
Species of Echinacea (primarily E. purpurea, E. angustifolia, and E. pallida) were used by numerous Native American peoples — including the Plains Nations — as topical wound treatments and for a variety of systemic ailments including respiratory complaints, snake bites, and toothaches. European Eclectic physicians adopted it in the 19th century for its purported immune-stimulating properties. Modern phytotherapy employs it primarily for upper respiratory tract infections in the form of standardized pressed juice, hydroethanolic extracts, or whole-root preparations.
Scientific Evidence
A 2023 systematic review and analysis concluded that echinacea may improve cold symptoms; however, the quality of the evidence was low to moderate. The Cochrane Collaboration has reviewed echinacea for the common cold on multiple occasions; results have been heterogeneous, partly due to the diversity of preparations and species studied. The efficacy of Echinacea is dubious based on identified studies: over 2,000 persons were given the treatment, but equal numbers of studies of good quality found positive and negative results.
NCCIH-sponsored research suggests that the activity of echinacea extracts is influenced by soil conditions that affect the plant's bacterial community. It is likely safe for most adults to consume products with extracts of E. purpurea, and some mixtures of E. purpurea and E. angustifolia, for short periods of time.
4.8 Elderberry (Sambucus nigra)
Traditional Use
The berries, flowers, bark, and leaves of elderberry have been used medicinally in European folk medicine for centuries. Elderberry preparations (wines, syrups, teas) were employed for fevers, colds, influenza, and sinus complaints. European traditional medicine references elderflower tea for catarrh and nasal congestion, while elder berry preparations appear in 17th–18th century European herbals.
Scientific Evidence
Taking elderberry may be helpful for cold and influenza symptoms and result in a quicker recovery. A 2023 review and analysis of three studies of South African geranium (Pelargonium sidoides) found moderate-quality evidence that it can improve cold symptoms. (Note: the elderberry evidence base is limited; all three clinical trials of elderberry concluded that it is effective against influenza, but only 77 persons were given the treatment in those trials combined, meaning the evidence base is small and focused on influenza rather than rhinosinusitis per se.)
4.9 Pelargonium sidoides (South African Geranium / Umckaloabo)
Traditional Use
Pelargonium sidoides root has a history of use in South African traditional (Zulu) medicine under the name "umckaloabo" for the treatment of respiratory tract infections, diarrhea, and liver complaints. The preparation was introduced to European medicine in the early 20th century and the standardized extract EPs 7630 has been studied extensively in Germany.
Scientific Evidence
A Cochrane systematic review by Timmer et al. evaluated Pelargonium sidoides extract for treating acute respiratory tract infections (Cochrane Database of Systematic Reviews, 2013, CD006323). The 2023 update of this review found moderate-quality evidence that the EPs 7630 extract can improve symptoms of the common cold and acute bronchitis. EPs 7630 is an 11% aqueous ethanolic extract in which 100 g of finished product corresponds to 8 g of extracted plant material; this was the formulation used in clinical trials but may be difficult to find in the United States. Evidence is rated as moderate quality; studies have primarily focused on overall symptom scores rather than nasal congestion as an isolated outcome.
4.10 Capsaicin
Traditional Use
Chili peppers (Capsicum spp.) have been cultivated and used culinarily and medicinally in the Americas for thousands of years. In Mesoamerican and South American traditional medicine, preparations containing hot peppers were used for respiratory and rheumatic conditions. In Ayurvedic medicine, pungent spices including related compounds have been used to clear the head and relieve catarrh.
Scientific Evidence
Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is the active component of chili peppers, plants of the genus Capsicum. Capsaicin is unique among naturally occurring irritant compounds because the initial neuronal excitation it evokes is followed by a long-lasting refractory period during which the previously excited neurons are no longer responsive to a broad range of stimuli. This process, known as defunctionalization, has been exploited for therapeutic use.
Intranasal capsaicin is currently considered one of the treatment options for non-allergic rhinitis. A scoping review in ScienceDirect found that seventeen studies reported positive effects of capsaicin on clinical outcomes for rhinitis, nasal polyposis, chronic cough, and pneumonia; sixteen studies reported on the safety of capsaicin, with no significant adverse events, though the evidence identified has limited implications for clinical practice and studies highlight emerging strands of research warranting further examination.
Critically, capsaicin has not been shown to be effective in allergic rhinitis nor in other forms of non-allergic rhinitis like the inflammatory endotypes or other neurogenic endotypes like rhinitis of the elderly or smoking-induced rhinitis. The available clinical evidence supports intranasal capsaicin specifically for idiopathic (neurogenic) non-allergic rhinitis. Evidence strength is moderate for this narrow indication and weak-to-absent for other subtypes.
4.11 Omega-3 Fatty Acids
Traditional Use
Cod liver oil, rich in EPA and DHA, has a centuries-long tradition of use in Scandinavian folk medicine for general health maintenance including respiratory well-being. Linseed (flaxseed) oil, high in alpha-linolenic acid (ALA), has similarly featured in European folk practice.
Scientific Evidence
Research in animal models has provided mechanistic insights: dietary linseed oil, which contains high amounts of alpha-linolenic acid (ALA), dampened allergic rhinitis through eosinophilic production of 15-hydroxyeicosapentaenoic acid (15-HEPE), a metabolite of EPA. Lipidomic analysis revealed that 15-HEPE was particularly accumulated in the nasal passage of linseed oil-fed mice after the development of allergic rhinitis. Intranasal injection of 15-HEPE dampened allergic symptoms by inhibiting mast cell degranulation, mediated by the action of peroxisome proliferator-activated receptor gamma. This is animal data; human clinical trial evidence for omega-3 supplementation specifically reducing nasal congestion scores remains limited and preliminary. The mechanistic plausibility is well established in preclinical work.
5. Saline Nasal Irrigation: A Distinct Evidence Category
Nasal saline irrigation occupies a unique category in that it operates via mechanical rather than pharmacological or nutritional mechanisms, yet it is widely discussed in natural-health contexts and has the strongest evidence base among non-pharmacological interventions for sinonasal complaints.
Nasal irrigation is an effective, safe, low-cost strategy for treating and preventing upper respiratory tract diseases, with high-volume, low-pressure saline irrigations being the most efficient method for removing infectious agents, allergens, and inflammatory mediators. Nasal irrigation improves symptoms, reduces recurrence, enhances the efficacy of topical drugs, and decreases the need for antibiotics and decongestants.
The physiological mechanisms underlying any benefit of nasal saline are not fully understood, but the primary mechanism of action is believed to be mechanical — including clearance of mucus, removal of airborne allergens and inflammation mediators such as histamine, with some evidence that at certain concentrations nasal saline may improve ciliary beat function and mucociliary function.
A systematic analysis revealed that nasal saline irrigation can significantly improve the local symptoms of allergic rhinitis in adults and children. The most commonly used solutions are isotonic saline (0.9%) and hypertonic saline (1.5–3%), both with an acidic pH (4.5–7); concentrations above 3% are not recommended due to dose-dependent complications such as pain, congestion, and rhinorrhea.
6. Dietary and Lifestyle Factors
6.1 Hydration and Fluid Intake
Adequate systemic hydration is widely discussed in the rhinosinusitis literature as a factor supporting mucociliary function. Adequate hydration helps thin mucus, making it easier to clear. This is consistent with the known role of the periciliary fluid layer in supporting ciliary beat efficiency, though large-scale clinical trials specifically measuring the effect of oral hydration on nasal congestion scores in controlled settings are limited.
6.2 Dietary Anti-Inflammatory Patterns
A diet rich in fruits, vegetables, and omega-3 fatty acids may support immune balance. Fruits and vegetables supply quercetin, vitamin C, beta-carotene, and numerous other polyphenols with potential relevance to mucosal immunity, as noted in the individual nutrient sections above. The Mediterranean diet pattern, which emphasizes these foods, has been associated with reduced inflammatory biomarkers in observational literature, though specific effects on rhinitis and sinusitis outcomes have not been extensively characterized in RCTs.
6.3 Spicy Foods and Gustatory Effects
Gustatory rhinitis happens when heat or spices activate the trigeminal nerve in the mucous membranes of the nose. This makes the nose produce mucus or a runny nose and dilates blood vessels in the nose, causing swelling and congestion. This represents a transient dietary trigger for nasal congestion in susceptible individuals rather than a therapeutic effect. Conversely, long-term intranasal capsaicin desensitization, as noted in Section 4.10, has a separate evidence base for idiopathic non-allergic rhinitis.
6.4 Allergen Avoidance and Environmental Control
According to the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines, allergic rhinitis is defined clinically by nasal hypersensitivity symptoms induced by an immunologically mediated (most often IgE-dependent) inflammation of the nasal mucous membranes after exposure to an offending allergen. Reducing exposure to identified allergens — including house dust mites, pet dander, and pollens — represents a foundational non-pharmacological strategy consistently endorsed in clinical guidelines. This includes measures such as allergen-proof mattress covers, HEPA filtration, and outdoor pollen monitoring.
6.5 Environmental Irritants Including Tobacco Smoke
Itching and sneezing are also natural responses to irritation caused by allergic reactions, chemical exposures including cigarette smoke, or temperature changes, infections, and other factors. Cigarette smoke is a well-documented trigger for both acute nasal congestion and chronic mucosal changes. Occupational chemical exposures, air pollutants, and indoor mold are similarly recognized as contributing factors to non-allergic rhinitis and rhinosinusitis in the literature.
6.6 Sleep, Stress, and the Immune System
Poor sleep and high stress can amplify immune responses and symptoms. Chronic psychological stress is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and altered immune reactivity, which may influence both allergic and non-allergic nasal inflammation. While this relationship is acknowledged in the clinical literature, rigorous intervention trials specifically targeting sleep or stress reduction as primary strategies for nasal congestion management are limited.
6.7 Obesity and Nasal Congestion
Epidemiological studies have identified associations between obesity and rhinitis. Adipose tissue is metabolically active and produces pro-inflammatory cytokines that may exacerbate nasal mucosal inflammation. Additionally, obstructive sleep apnea — which shares a well-documented relationship with obesity — features chronic nasal congestion as both a contributory and accompanying symptom. Nasal congestion can contribute to the onset or worsening of sleep disturbances, including obstructive sleep apnea.
7. Summary of Evidence Strength
- Saline nasal irrigation: Strong evidence from multiple systematic reviews and RCTs for symptom reduction in allergic rhinitis, acute and chronic rhinosinusitis.
- Zinc (oral lozenges): Moderate evidence for shortening cold duration when taken within 24 hours of symptom onset; inconsistent across trials due to dose and formulation variation.
- Vitamin C: Moderate evidence for modest symptom-severity reduction and duration shortening as adjunct; does not prevent colds in the general population.
- Vitamin D: Preliminary-to-moderate evidence from meta-analyses for reducing total nasal symptom scores in allergic rhinitis, with high inter-study heterogeneity.
- Bromelain: Weak-to-moderate evidence from small and non-randomized studies in acute sinusitis, particularly in children; larger, blinded RCTs are absent.
- Quercetin: In vitro and animal evidence is robust; human clinical trial evidence is very limited (two monotherapy trials), though mechanistically compelling.
- NAC: Established mucolytic mechanism; clinical trial evidence in rhinosinusitis is preliminary and methodologically weak; well-designed RCTs are needed.
- Echinacea: Low-to-moderate evidence for cold symptom improvement; highly heterogeneous literature; no species/preparation universally preferred.
- Elderberry: Small body of clinical evidence suggesting benefit in influenza-related symptoms; limited data specifically on nasal congestion.
- Pelargonium sidoides: Moderate Cochrane-level evidence for acute respiratory tract infection symptom improvement.
- Intranasal capsaicin: Moderate evidence specifically for idiopathic non-allergic rhinitis; not effective for allergic rhinitis.
- Omega-3 fatty acids: Strong preclinical mechanistic evidence; human clinical trial data for nasal congestion specifically are sparse.
References
Go back